The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

MLA

Liu, Suhu, et al. “The Kinases IKBKE and TBK1 Regulate MYC-Dependent Survival Pathways through YB-1 in AML and Are Targets for Therapy.” Blood Advances, vol. 2, no. 23, Dec. 2018, pp. 3428–42. EBSCOhost, https://doi.org/10.1182/bloodadvances.2018016733.

APA

Liu, S., Marneth, A. E., Alexe, G., Walker, S. R., Gandler, H. I., Ye, D. Q., Labella, K., Mathur, R., Toniolo, P. A., Tillgren, M., Gokhale, P. C., Barbie, D., Mullally, A., Stegmaier, K., & Frank, D. A. (2018). The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy. Blood Advances, 2(23), 3428–3442. https://doi.org/10.1182/bloodadvances.2018016733

Chicago

Liu, Suhu, Anna E Marneth, Gabriela Alexe, Sarah R Walker, Helen I Gandler, Darwin Q Ye, Katherine Labella, et al. 2018. “The Kinases IKBKE and TBK1 Regulate MYC-Dependent Survival Pathways through YB-1 in AML and Are Targets for Therapy.” Blood Advances 2 (23): 3428–42. doi:10.1182/bloodadvances.2018016733.